| Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy RE Polk, C Fox, A Mahoney, J Letcavage, C MacDougall Clinical infectious diseases 44 (5), 664-670, 2007 | 471 | 2007 |
| Antimicrobial use and bacterial resistance S Monroe, R Polk Current opinion in microbiology 3 (5), 496-501, 2000 | 381 | 2000 |
| Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers RE Polk, DP Healy, J Sahai, L Drwal, E Racht Antimicrobial agents and chemotherapy 33 (11), 1841-1844, 1989 | 270 | 1989 |
| Hospital and Community Fluoroquinolone Use and Resistance in Staphylococcus aureus and Escherichia coli in 17 US Hospitals C MacDougall, JP Powell, CK Johnson, MB Edmond, RE Polk Clinical infectious diseases 41 (4), 435-440, 2005 | 217 | 2005 |
| Relationship of Carbapenem Restriction in 22 University Teaching Hospitals to Carbapenem Use and Carbapenem-Resistant Pseudomonas aeruginosa AL Pakyz, M Oinonen, RE Polk Antimicrobial agents and chemotherapy 53 (5), 1983-1986, 2009 | 201 | 2009 |
| Trends in antibacterial use in US academic health centers: 2002 to 2006 AL Pakyz, C MacDougall, M Oinonen, RE Polk Archives of internal medicine 168 (20), 2254-2260, 2008 | 194 | 2008 |
| Vancomycin-induced histamine release and" red man syndrome": comparison of 1-and 2-hour infusions DP Healy, JV Sahai, SH Fuller, RE Polk Antimicrobial agents and chemotherapy 34 (4), 550-554, 1990 | 165 | 1990 |
| Antimicrobial Use Metrics and Benchmarking to Improve Stewardship Outcomes Methodology, Opportunities, and Challenges O Ibrahim, RE Polk Infect Dis Clin N Am 28, 195–214, 2014 | 158 | 2014 |
| Benchmarking Risk-Adjusted Adult Antibacterial Drug Use in 70 US Academic Medical Center Hospitals RE Polk, SF Hohmann, S Medvedev, I O. Clinical Infectious Diseases 53 (11), 1100–10, 2011 | 158 | 2011 |
| Predicting Hospital Rates of Fluoroquinolone-Resistant Pseudomonas aeruginosa from Fluoroquinolone Use in US Hospitals and Their Surrounding Communities RE Polk, CK Johnson, D McClish, RP Wenzel, MB Edmond Clinical infectious diseases 39 (4), 497-503, 2004 | 144 | 2004 |
| Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram PP Cook, PG Catrou, JD Christie, PD Young, RE Polk Journal of Antimicrobial Chemotherapy 53 (5), 853-859, 2004 | 144 | 2004 |
| Pharmacokinetics of [14C]Abacavir, a Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase Inhibitor, Administered in a Single Oral Dose to HIV-1 … JA McDowell, GE Chittick, JR Ravitch, RE Polk, TM Kerkering, DS Stein Antimicrobial agents and chemotherapy 43 (12), 2855-2861, 1999 | 122 | 1999 |
| Comparison of vancomycin-and teicoplanin-induced histamine release and" red man syndrome" J Sahai, DP Healy, MJ Shelton, JS Miller, SJ Ruberg, R Polk Antimicrobial agents and chemotherapy 34 (5), 765-769, 1990 | 119 | 1990 |
| Sulfadiazine-induced crystalluria in a patient with the acquired immunodeficiency syndrome: a reminder. J Sahai, T Heimberger, K Collins, L Kaplowitz, R Polk | 119 | 1988 |
| Pharmacokinetic interaction between amprenavir and rifabutin or rifampin in healthy males RE Polk, DF Brophy, DS Israel, R Patron, BM Sadler, GE Chittick, ... Antimicrobial agents and chemotherapy 45 (2), 502-508, 2001 | 112 | 2001 |
| The influence of chronic administration of calcium carbonate on the bioavailability of oral ciprofloxacin. J Sahai, DP Healy, J Stotka, RE Polk British journal of clinical pharmacology 35 (3), 302, 1993 | 97 | 1993 |
| Variability in rates of use of antibacterials among 130 US hospitals and risk-adjustment models for interhospital comparison C MacDougall, RE Polk Infection Control & Hospital Epidemiology 29 (3), 203-211, 2008 | 85 | 2008 |
| Benchmarking antimicrobial drug use in hospitals O Ibrahim, RE Polk Expert Rev. Anti Infect. Ther 10 (4), 445–457, 2012 | 84 | 2012 |
| Vancomycin skin tests and prediction of" red man syndrome" in healthy volunteers RE Polk, D Israel, J Wang, J Venitz, J Miller, J Stotka Antimicrobial agents and chemotherapy 37 (10), 2139-2143, 1993 | 66 | 1993 |
| Statin use and the risk of Clostridium difficile in academic medical centres CA Motzkus-Feagans, A Pakyz, R Polk, G Gambassi, KL Lapane Gut 61 (11), 1538-1542, 2012 | 64 | 2012 |
